New graft may help heal stubborn diabetic foot sores
NCT ID NCT07219004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a tri-layer amnion/chorion/amnion graft (Artacent-AC) plus standard care helps heal chronic diabetic foot ulcers better than standard care alone. 30 adults with diabetes and non-healing foot sores took part. The main goal was to see if the wound fully closed within 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER (DFU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
El Campo Memorial Advanced Wound Care Clinic
El Campo, Texas, 77437, United States
-
Serena Group
Monroeville, Pennsylvania, 15146, United States
-
Serena Group Reseach Center
Buffalo, New York, 14203, United States
-
The Serena Group Austin Research Center
Austin, Texas, 78701, United States
-
Three Rivers Wound and Hyperbaric Center
North Port, Florida, 34289, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a united team heal stubborn ulcers faster?
- New wound dressings aim to heal stubborn diabetic and leg ulcers
- Amniotic membrane wraps show promise for stubborn wounds
- Placental grafts show promise for stubborn diabetic foot sores
- Can the right words prevent diabetic foot ulcers? new study investigates
- New silicone dressings show promise for chronic leg ulcers